SAN FRANCISCO — For companies that monitor and coach patients with chronic disease, there are few things more valuable than data on how those patients are faring at any given moment. Now, one of those companies, Livongo (LVGO), is about to have vastly more information on thousands of its members with diabetes.
Livongo announced Monday that it will integrate a continuous glucose monitor made by Dexcom (DXCM), the big manufacturer in the space, into its system. That blockbuster device, called the G6 CGM system, reads a diabetes patient’s blood glucose level every five minutes — offering 288 data points a day that Livongo can mine for insights to try to help patients manage their disease.
Currently, Livongo gets blood sugar data from its members with diabetes only a handful of times a day.